These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11433775)

  • 1. [Crystalline molecular complexes generated between surfactants and various additive compounds: an attempt to modify sparingly water soluble drugs to easily water soluble drugs].
    Hirata H; Iimura N
    Yakugaku Zasshi; 2001 Jun; 121(6):403-21. PubMed ID: 11433775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs.
    Park SH; Choi HK
    Int J Pharm; 2006 Sep; 321(1-2):35-41. PubMed ID: 16797892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
    Al-Obaidi H; Lawrence MJ; Buckton G
    J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure.
    Vinarov Z; Katev V; Radeva D; Tcholakova S; Denkov ND
    Drug Dev Ind Pharm; 2018 Apr; 44(4):677-686. PubMed ID: 29164955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-dissolution and de-compaction of DNA-cationic surfactant complexes using non-ionic surfactants.
    Corbyn CP; Fletcher PD; Gemici R; Dias RS; Miguel MG
    Phys Chem Chem Phys; 2009 Dec; 11(48):11568-76. PubMed ID: 20024429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Modeling of Micellar Solubilization by Single and Mixed Nonionic Surfactants.
    Feng S; Catron ND; Zhu AD; Lipari JM; Wu J; Gao Y; Zhang GGZ
    J Pharm Sci; 2018 Aug; 107(8):2079-2090. PubMed ID: 29548976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of Cationic Surfactants to Lipid-Based Formulations of Poorly Water-Soluble Acidic Drugs Alters the Phase Distribution and the Solid-State Form of the Precipitate Upon In Vitro Lipolysis.
    Khan J; Rades T; Boyd BJ
    J Pharm Sci; 2018 Sep; 107(9):2420-2427. PubMed ID: 29859958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.
    Balakrishnan A; Rege BD; Amidon GL; Polli JE
    J Pharm Sci; 2004 Aug; 93(8):2064-75. PubMed ID: 15236455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems.
    Chidambaram N; Burgess DJ
    AAPS PharmSci; 2000; 2(3):E28. PubMed ID: 11741244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel cosmetic base using sterol surfactant. II. Solubilizing of sparingly soluble ultraviolet ray absorbers.
    Teshigawara T; Miyahara R; Fukuhara T; Oka T
    J Oleo Sci; 2009; 58(1):27-36. PubMed ID: 19075505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The applicability of sucrose laurate in hot-melt technology].
    Lang P; Szuts A; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2011; 81(1):43-6. PubMed ID: 21595305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process.
    Nozawa K; Iwao Y; Noguchi S; Itai S
    Int J Pharm; 2015 Nov; 495(1):204-217. PubMed ID: 26325306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.
    Rodríguez-Hornedo N; Murphy D
    J Pharm Sci; 2004 Feb; 93(2):449-60. PubMed ID: 14705201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
    Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
    J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysozyme in catanionic surfactant mixtures.
    Stenstam A; Khan A; Wennerström H
    Langmuir; 2004 Aug; 20(18):7760-5. PubMed ID: 15323529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.
    Tarsa PB; Towler CS; Woollam G; Berghausen J
    Eur J Pharm Sci; 2010 Sep; 41(1):23-30. PubMed ID: 20553863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomistic simulation study of surfactant and polymer interactions on the surface of a fenofibrate crystal.
    Zhu W; Romanski FS; Meng X; Mitra S; Tomassone MS
    Eur J Pharm Sci; 2011 Apr; 42(5):452-61. PubMed ID: 21291999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.